Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT05973617
Other study ID # 005-2021-SN
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date December 2022
Est. completion date June 2023

Study information

Verified date August 2023
Source Aston University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the study is to use machine learning to develop an IT tool able to differentiate between eye conditions analysing corneal biomechanical data.


Description:

Data will be collected using two different commercially available devices that are able to measure corneal biomechanics. Corneal biomechanics will be measured in participants with different conditions: glaucoma, ocular hypertension, corneal conditions, and healthy controls as it is well established that the above-mentioned conditions cause changes in corneal biomechanical properties. Corneal biomechanics are the mechanical properties of the cornea, as rigidity, elasticity and it is possible to measure them using two devices: Ocular Response Analyzer (ORA) or Corneal Visualization Scheimpflug Technology (Corvis ST). Both devices use a puff of air to temporally flatten the cornea and derive the properties of the tissue. Participants with ocular conditions will be recruited at Birmingham and Midlands Eye Centre (BMEC) at the Glaucoma and Anterior Eye clinics among patients attending for their routine clinical appointment. Healthy controls will be recruited at Aston University. This study requires only one visit and there is no need of follow up. A portion of the data collected will be used to train machine learning algorithms to differentiate between conditions, the remaining data will be used to test the accuracy of newly created algorithms. The algorithm will be developed using Orange Data Mining.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2023
Est. primary completion date June 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age above 18 years old. - Participants who are able to give informed consent. - Study groups: Patients with diagnosis of glaucoma or corneal disease or ocular hypertension. Patients that are having a treatment (medications or surgery) for glaucoma or ocular hypertension or corneal conditions. - Control group: people with no diagnosis or treatment of previous pathologies. Exclusion Criteria: - Age below 18. - Participants who are not able to give informed consent. - Patients with eye conditions not within the inclusion criteria. - Patients with respiratory distress or significant head tremor. - Patients who are in pain or unable to remain seated for duration of measurements. - Participants that during the visit are wearing contact lenses. The wear of contact lenses can alter the measure of corneal biomechanics.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Measurement of corneal biomechanical properties
Measurement of corneal biomechanics

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Aston University Sandwell & West Birmingham Hospitals NHS Trust

Outcome

Type Measure Description Time frame Safety issue
Primary First applanation velocity Velocity during the first applanation of the cornea, measured using Corivs ST [m/s] Day 1
Primary First applanation time Time frame of the first applanation of the cornea, measured using Corivs ST [s] Day 1
Primary First applanation lenght Lenght of the first applanation of the cornea, measured using Corivs ST [mm] Day 1
Primary Second applanation velocity Velocity during the second applanation of the cornea, measured using Corivs ST [m/s] Day 1
Primary Second applanation time Time frame of the second applanation of the cornea, measured using Corivs ST [s] Day 1
Primary Second applanation lenght Lenght of the second applanation of the cornea, measured using Corivs ST [mm] Day 1
Primary Highest concavity time Time frame at highest concavity, measured using Corivs ST [s] Day 1
Primary Highest concavity peak distance Distance between the 2 surrounding peaks at the highest concavity, measured using Corivs ST [mm] Day 1
Primary Highest concavity radius Radius of curvature at highest concavity, measured using Corivs ST [mm] Day 1
Primary Highest concavity deformation amplitude Maximal displacement of corneal apex between normal corneal shape and highest concavity, measured using Corivs ST [mm] Day 1
Primary Corneal hysteresis Difference in terms of intensity of puff of air between the first and second applanation, measured using ORA [mmHg] Day 1
Primary Corneal resistance factor Overall resistance of the cornea, measured using ORA [mmHg] Day 1
Secondary Intraocular pressure measured using Corvis ST Value of intraocular pressure measured according to the pressure of the air needed to applanate the cornea. Day 1
Secondary Intraocular pressure measured using ORA Value of intraocular pressure measured according to the pressure of the air needed to applanate the cornea. Day 1
Secondary Pachymetry Measure of corneal thickness using Corvis ST Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT05414994 - Assessment of the Ocular Microbiome in Health and Disease
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Completed NCT02811692 - Study for Collection of Aflibercept Data in Routine Practice
Recruiting NCT06045299 - Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia Phase 3
Recruiting NCT01521065 - An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration Phase 2
Completed NCT04799704 - Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.
Recruiting NCT05876689 - Swept Source OCT Imaging With the DREAM VG-OCT
Active, not recruiting NCT04123626 - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene Phase 1/Phase 2
Recruiting NCT04150432 - Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children N/A
Not yet recruiting NCT05550740 - Repeated Low-Level Red-Light Therapy for Shortening Axial Length N/A
Completed NCT02332343 - Sparing of the Fovea in Geographic Atrophy Progression N/A
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Terminated NCT01225146 - Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2) Phase 1
Completed NCT00333203 - Next Generation Ophthalmic Irrigating Solution Posterior Segment Study Phase 3
Not yet recruiting NCT05565547 - Multimodal Equipment for Teleophthalmology Assessment (META)
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Recruiting NCT06112340 - A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) Phase 2/Phase 3
Completed NCT05211089 - Manual Versus Automated Choroidal Thickness Measurements Using Swept-source Anterior Segment OCT
Not yet recruiting NCT06070467 - Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases
Completed NCT02946879 - Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)